Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising $80 million to fund Phase 2.

Bitcoin price momentum accelerated, with big overhead resistance at $135,000 in place and several key support levels below.

Fund managers are under pressure to deploy capital quickly and risk buying bad assets

XRP’s legal victory reshaped investor confidence, establishing it as a preferred choice for investors seeking regulated, liquid crypto assets.

The acquisition strengthens Rezolve’s partnership with Tether and expands its AI-driven digital payments network across Latin America and Africa.